Advanced Bugs and Drugs (Adv. AS Curriculum)

Target Audience

Ideal for medical students, residents, fellows and others who desire to expand their knowledge of key microbiology and pharmacology concepts. This course can be used collaboratively in a classroom setting, or completed independently. Please reach out to for more information about how to best utilize this curriculum for your particular needs.

Learning Objectives

Module 1: Drugs Foundation
Module 2: The Steward's Corner
Module 3: Case 1 - KPC
Module 4: Case 2 - Invasive Candidiasis
Module 5: Case 3 - HSV

Microbiological Learning Objectives   

  • Discuss rapid diagnostic and resistance/susceptibility testing principles most important to pathogens relevant to stewardship (KPC, Candida spp, HSV). 
  • Describe principles of phenotypic susceptibility testing, MIC interpretation and apply practical CLSI data effectively relevant to cases (KPC, Candida spp. HSV). 
  • Outline opportunities for integration of microbiology lab into antimicrobial stewardship initiatives (relevant to both susceptibility testing/reporting and rapid diagnostics/lab stewardship) 

Pharmacotherapeutics Learning Objectives 

  • Customize antimicrobial agent selection based on available phenotypic and/or genotypic microbiological testing results. 
  • Customize antimicrobial dosage regimens based on available phenotypic and/or genotypic microbiological testing results 
  • Apply PK/PD data, target indices, and therapeutic drug monitoring to the design of appropriate antimicrobial regimens for patients with altered pharmacokinetics and/or in special populations. 
Course summary
Course opens: 
Course expires: 
NameIndividual's role in activityName of commercial interestNature of Relationship
Al Lawati, HawraWorkgroup MemberNone 
Babiker, AhmedPanelistN/AN/A
Beeler, ColeWorkgroup MemberNone 
Bennani, KenzaStaffNone 
Brennan - Krohn, TheaWorkgroup MemberNone 
Bryson - Cahn, ChloeWorkgroup MemberNone 
Fong, GaryWorkgroup MemberCritical Innovations, LLCAdvisory/Consultant Role
Gaston, David CPanelistIllumina, IncResearch reagents
  IDbyDNA, IncResearch reagents
  bioMerieux, IncScientific advisory board
Huang, MishaWorkgroup MemberNone 
Humphries, RomneyPanelistbioMerieux
Specific Diagnostics
Research funding
Justo, Julie AnnWorkgroup MemberbioMerieuxOther remuneration - Speaker's Bureau
  MerckAdvisory/Consultant Role
Kang, AmyWorkgroup MemberNone 
Logan, AshleighStaffNone 
Luther, VeraWorkgroup MemberNone 
MacDougall, ConanWorkgroup MemberNone 
Miller, MattWorkgroup MemberAbbvieHonoraria
  La JollaHonoraria
  MerckResearch Grant/Contract
Moenster, RyanWorkgroup MemberShionogiAdvisory/Consultant Role, Honoraria
  Abbvie/AllerganAdvisory/Consultant Role, Honoraria
  Melinta TherapeuticsAdvisory/Consultant Role, Honoraria
  MerckAdvisory/Consultant Role, Honoraria
Nori, PriyaWorkgroup ChairMerckCo-infections in COVID-19 patients
Paras, MollyWorkgroup MemberNone 
Rodvold, KeithWorkgroup MemberBLC USA LPAdvisory/Consultant Role, Honoraria
  VenatoRxAdvisory/Consultant Role, Honoraria
  Medicine Company/Qpex BiopharmaAdvisory/Consultant Role, Honoraria
  Vemco Med Ed. (Merck CME/CPE programs)Advisory/Consultant Role, Honoraria
  DebipharmAdvisory/Consultant Role, Honoraria
  ShionogiAdvisory/Consultant Role, Honoraria
   Unrestricted education grant for CME/CPE Program
  Utility TherapeuticsAdvisory/Consultant Role, Honoraria
  JanssenData Safety Monitoring Board (DSMB)
  Clinartis LLC (projects associated with Spero Therapeutics and Sinovent)Advisory/Consultant Role, Honoraria
  USCAST : US Ctte on Antimicrobial Susceptibility TestingVoting Committee Member
Spicer, JenniferWorkgroup MemberNone 
Stead, WendyWorkgroup MemberNone 
Stohs, EricaWorkgroup MemberReviral LtdResearch Grant
Shnekendorf, RachelStaffNone 

Vaezi, Liza

Workgroup MemberNone 
Williams, RostamStaffNone 


This version of the curriculum is not accredited for CME or MOC.

Please login or register to take this course.

Required Hardware/software

PCs Running Window

  • Windows 10  
  • Microsoft Edge
  • Firefox
  • Google Chrome

Apple Computers Running OSX

  • Safari
  • Firefox
  • Google Chrome